New insider activity at Aveanna Healthcare Holdings ( (AVAH) ) has taken place on May 21, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aveanna Healthcare Holdings’ Chief Commercial Officer, Patrick A. Cunningham, recently executed a significant stock transaction, selling 125,000 shares of the company’s stock for a total value of $947,500. This insider sale highlights notable trading activity within Aveanna’s executive ranks and may draw attention from investors monitoring leadership moves and ownership changes at the company.
Recent Updates on AVAH stock
Aveanna Healthcare shares reacted to multiple analyst revisions following a strong Q1 beat, raised guidance, and a detailed 2026 outlook showing solid revenue growth, margin expansion, and scale in pediatric homecare. Targets were adjusted as analysts weighed brisk Core Private Duty demand, success of the preferred payor strategy, improved EBITDA versus guidance, and limited expected impact from a new home health moratorium, against ongoing leverage and balance sheet risk.
Spark’s Take on AVAH Stock
According to Spark, TipRanks’ AI Analyst, AVAH is a Outperform.
The score is driven by improving profitability/cash generation and very low valuation, supported by raised guidance and solid operational momentum. The primary risk limiting the score is the highly leveraged balance sheet and sensitivity to labor costs and cash flow consistency.
To see Spark’s full report on AVAH stock, click here.
More about Aveanna Healthcare Holdings
YTD Price Performance: -6.00%
Average Trading Volume: 1,344,382
Technical Sentiment Signal: Buy
Current Market Cap: $1.67B